New York, NY - May 25, 2012 - www.InvestorIdeas.com, a global investor research specializing in sector research including China stocks, issues an investor alert for Complete Genomics, Inc. (NasdaqGM: GNOM), continuing on yesterday’s gains, trading up at $3.03, up 0.70 (30.04%) 10:30AM EDT on over 9 Million shares . GNOM is the top percentage gainer on NASDAQ as of the time of this report.
The Company announced earlier this month that it had sequenced the
genomes of 600 individuals from 20 Mexican-American families from San
Antonio in what is thought to be the largest whole genome sequencing
family study conducted to date and the first such study of its kind in a
About Complete Genomics
Complete Genomics is the whole human genome sequencing company that has developed and commercialized an innovative
DNA sequencing service. The Complete Genomics Analysis Platform
(CGA(TM) Platform) combines Complete Genomics' proprietary human genome
sequencing technology with advanced informatics and data management software. Additional information can be found at http://www.completegenomics.com
Research more biotech and pharma stocks with Investorideas.com global stock directory :
InvestorIdeas.com is a leader in investor stock research by sector.
Sectors we cover include; China stocks, renewable energy stocks,
biotech stocks, mining and gold stocks, energy stocks, water, tech,
defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Get Free investor news and stock alerts at Investorideas.com
Join Investor Ideas Get 13 of the best stock directories online;
Research China stocks, oil and gas stocks, gold stocks,
water stocks, renewable energy stocks (over 1300 green stocks in
directory) and more
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy
or sell products or securities. We attempt to research thoroughly, but
we offer no guarantees as to the accuracy of information presented. All
Information relating to featured companies is sourced from public
documents and/ or the company and is not the opinion of our web sites.
This site is currently compensated by featured companies, news
submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
Source - www.Investorideas.com